ESCRS - PP09.01 - Therapeutic Topography-Guided Photorefractive Keratectomy (Tg-Prk) Combined With Corneal Collagen Crosslinking (Cxl) In Keratoconus Patients

Therapeutic Topography-Guided Photorefractive Keratectomy (Tg-Prk) Combined With Corneal Collagen Crosslinking (Cxl) In Keratoconus Patients

Published 2022 - 40th Congress of the ESCRS

Reference: PP09.01 | Type: ESCRS 2022 - Posters | DOI: 10.82333/67th-jn68

Authors: Niraj Mandal* 1 , Simon Holland 1 , David Lin 1 , Greg Moloney 1 , Geoffrey Ching 1 , Amir Ismail 1

1Department of Ophthalmology and Visual Sciences,University of British Columbia, Vancouver, Canada,Vancouver,Canada

Purpose

Keratoconus is a progressive ectatic disorder of the cornea which often presents with fluctuating refraction and high irregular astigmatism and traditionally has been a contraindication for traditional refractive laser treatments.  Topography-guided photorefractive keratectomy (Tg-PRK) is a customized laser ablation, enabling specific targeting of corneal irregularity which can help regularise the cornea resulting in improved corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA).

Setting

Laser clinic in Vancouver  

Methods

Retrospective consecutive series of 54 keratoconic eyes undergoing TG-PRK followed by collogen crosslinking (CXL) Schwind Amaris 1050. Images were captured with the Schwind Sirius and CXL was perfomed as per the Athens protocol.  Mitomycin  0.02% was used in all cases. Preoperative and post-operative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction (MR) and topographic cylinder were analyzed. All Cases with sufficient data at 24 months follow-up were included.

Results

54 patients had sufficient data at 24 months for analysis as per our methodology. 50% of patients (27/54) had a UDVA ≥20/40 . 42% (22/54) CDVA improved ≥ 1 line. 26% (14/54) CDVA improved ≥ 2 lines. 13.2% (7/54) lost ≥2 lines. Mean astigmatism reduced from 3.14±1.56D to 2.18±1.74D (p<0.0001). Mean spherical equivalent reduced from -2.51±3.48D to -0.69±2.24D (p<0.0001).

Conclusions

TG-PRK CXL shows efficacy and safety for eyes with keratoconus, with half of patients achieving 20/40 UDVA or better. 42% had improved CDVA with more than a quarter improving 2 or more lines providing an alternative to contact lens intolerant keratoconus patients.